⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13949521 | 0.72 | — | — | |
| SCHEMBL62470 | 0.72 | — | — | |
| SCHEMBL5883199 | 0.67 | — | — | |
| SCHEMBL28809967 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL7949079 | 0.67 | — | — | |
| SCHEMBL24134604 | 0.62 | — | — | |
| Hydrochloric Acid SCHEMBL5607257 | 0.62 | — | — | |
| SCHEMBL14221295 | 0.62 | — | — | |
| SCHEMBL22705194 | 0.62 | — | — | |
| SCHEMBL14221447 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11339147-B2 | Lactam compound as FXR receptor agonist | CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (CN) | 2022-05-24 | — | — | US | disclosed |
| US-20200190074-A1 | LACTAM COMPOUND AS FXR RECEPTOR AGONIST | MEDSHINE DISCOVERY INC. (CN) | 2020-06-18 | — | — | US | disclosed |